Skip to main content

FDA Approves First Erectile Dysfunction Gel That Doesn't Require a Prescription

FDA Approves First Erectile Dysfunction Gel That Doesn't Require a Prescription

Those looking for a good time — but having a harder time downstairs — may finally have a solution that doesn't require a prescription: the suggestively named Eroxon, a topical erectile dysfunction gel that has just been authorized by the Food and Drug Administration for over-the-counter use.

Futura Medical, the British pharmaceutical firm behind the drug, announced the FDA's approval on Monday.

The release notes that the FDA has given Eroxon a "de novo" classification, meaning the drug is the first gel or topical treatment for erectile dysfunction to have been approved, let alone be authorized for sale without a doctor's prescription.

While many sufferers may find it embarrassing to admit having it, erectile dysfunction is a pretty widespread problem. According to the National Institutes for Health, some 30 million men in the US are affected by the condition, which makes it difficult for someone to achieve and maintain an erection. It's especially common in men over 40, and by the age of 70, it's virtually the norm, with 70 percent of men in that age bracket reporting to be affected, according to the NIH.

The factors that cause or contribute to the condition can range significantly, from type 2 diabetes to the use of antidepressants. And that's not to mention the many psychological factors, such as anxiety or depression.

Futura Medical makes some big claims about its new drug. While popular pills like Viagra and Cialis can take between 30 to 60 minutes to kick into action, the company advertises that Eroxon starts working within just ten minutes.

You can probably thank its topical application for that. Since it's a gel, Eroxon cuts to the chase and is applied directly to the head of the penis, which its instructions candidly note, can be done "as part of foreplay." Double the fun!

Futura is a little more vague on how long the effects persist — but it's "long enough," at least, "for successful intercourse," according to the company's website.

Still, whether Eroxon could be the more affordable alternative is harder to say as it isn't being sold in the US just yet. CNN notes that in the United Kingdom, where Eroxon is already being sold, a pack of four retails for about $36.99.

Name brand Viagra and Cialis pills can be ludicrously expensive in the US, but generic versions are usually far cheaper.

Either way, once Eroxon hits the shelves, it'll soon be easier than ever for guys with penis problems to get the fix they need.



Comments

Popular posts from this blog

Who is the first and only President to instigate a coup?

Dark Brandon Vs Donald Hoover Trump

Can MAGA Insurrectionists Launch Attacks Against the Supreme Court Over its Rulings? Exploring the Limits of Political Influence on Judicial Decisions

Can MAGA Insurrectionists Launch Attacks Against the Supreme Court Over its Rulings? Exploring the Limits of Political Influence on Judicial Decisions. In the wake of contentious legal battles and polarizing decisions, the question arises: Can the "Make America Great Again" (MAGA) movement launch attacks against the Supreme Court over its rulings? As the highest court in the land, the U.S. Supreme Court is often a focal point of scrutiny and criticism from various political factions, but the extent to which these attacks can influence or undermine its authority is a matter of debate and legal interpretation. Historical Context:  Throughout American history, the Supreme Court has faced criticism and resistance from various quarters. From landmark decisions on civil rights and social issues to contentious rulings on political matters, the Court has been no stranger to public backlash. However, the principles of judicial independence and the separation of powers enshrined in the

Treatment of erectile dysfunction in adult males aged 22 years and over

  Treatment of erectile dysfunction in adult males aged 22 years and over . U.S. Food & Drug Administration 10903 New Hampshire Avenue Doc ID# 04017.0 6 . 0 2 Silver Spring, M D 20993 www.fda.gov June 9, 2023 Re: DEN220078 Trade/Device Name: Eroxon Regulation Number: 21 CFR 876.5021 Regulation Name: Non- medicated top ical formula tion for trea tment of erec tile dysfu nction Regulatory Class: II Product Code: QWW Dated: January 4, 2023 Received: March 28, 2023 Dear Ken James: The Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) has completed its review of your De Novo request for classification of the Eroxon, an over- the - counter device under 21 CFR Part 801 Subpart C with the following indications for use: Treatment of erectile dysfunction in adult males aged 22 years and over. FDA concludes that this device should be classified into Class II. Th is order, therefor